Von Hoff DD - Search Results

1

Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.

Hurley LH, Von Hoff DD, Siddiqui-Jain A, Yang D. Hurley LH, et al. Among authors: von hoff dd. Semin Oncol. 2006 Aug;33(4):498-512. doi: 10.1053/j.seminoncol.2006.04.012. Semin Oncol. 2006. PMID: 16890804 Review.

2

Telomerase assay using biotinylated-primer extension and magnetic separation of the products.

Sun D, Hurley LH, Von Hoff DD. Sun D, et al. Among authors: von hoff dd. Biotechniques. 1998 Dec;25(6):1046-51. doi: 10.2144/98256cr03. Biotechniques. 1998. PMID: 9863060 Free article.

3

Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.

Izbicka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, Sun D, Windle BE, Hurley LH, Von Hoff DD. Izbicka E, et al. Among authors: von hoff dd. Cancer Res. 1999 Feb 1;59(3):639-44. Cancer Res. 1999. PMID: 9973212

4

Regulation of catalytic activity and processivity of human telomerase.

Sun D, Lopez-Guajardo CC, Quada J, Hurley LH, Von Hoff DD. Sun D, et al. Among authors: von hoff dd. Biochemistry. 1999 Mar 30;38(13):4037-44. doi: 10.1021/bi982249n. Biochemistry. 1999. PMID: 10194316

5

Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.

Izbicka E, Nishioka D, Marcell V, Raymond E, Davidson KK, Lawrence RA, Wheelhouse RT, Hurley LH, Wu RS, Von Hoff DD. Izbicka E, et al. Among authors: von hoff dd. Anticancer Drug Des. 1999 Aug;14(4):355-65. Anticancer Drug Des. 1999. PMID: 10625928

6

G-quadruplexes as targets for drug design.

Hurley LH, Wheelhouse RT, Sun D, Kerwin SM, Salazar M, Fedoroff OY, Han FX, Han H, Izbicka E, Von Hoff DD. Hurley LH, et al. Among authors: von hoff dd. Pharmacol Ther. 2000 Mar;85(3):141-58. doi: 10.1016/s0163-7258(99)00068-6. Pharmacol Ther. 2000. PMID: 10739869 Review.

7

DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs.

Raymond E, Soria JC, Izbicka E, Boussin F, Hurley L, Von Hoff DD. Raymond E, et al. Among authors: von hoff dd. Invest New Drugs. 2000 May;18(2):123-37. doi: 10.1023/a:1006373812586. Invest New Drugs. 2000. PMID: 10857992 Review.

8

Telomere maintenance mechanisms as a target for drug development.

Bearss DJ, Hurley LH, Von Hoff DD. Bearss DJ, et al. Among authors: von hoff dd. Oncogene. 2000 Dec 27;19(56):6632-41. doi: 10.1038/sj.onc.1204092. Oncogene. 2000. PMID: 11426649 Review.

9

Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects.

Duan W, Rangan A, Vankayalapati H, Kim MY, Zeng Q, Sun D, Han H, Fedoroff OY, Nishioka D, Rha SY, Izbicka E, Von Hoff DD, Hurley LH. Duan W, et al. Among authors: von hoff dd. Mol Cancer Ther. 2001 Dec;1(2):103-20. Mol Cancer Ther. 2001. PMID: 12467228

10

The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.

Grand CL, Han H, Muñoz RM, Weitman S, Von Hoff DD, Hurley LH, Bearss DJ. Grand CL, et al. Among authors: von hoff dd. Mol Cancer Ther. 2002 Jun;1(8):565-73. Mol Cancer Ther. 2002. PMID: 12479216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters